Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2259 | 4678 | 47.8 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
100 | 3 | NEUROSCIENCES//METABOTROPIC GLUTAMATE RECEPTOR//HIPPOCAMPUS | 73970 |
2259 | 2 | METABOTROPIC GLUTAMATE RECEPTOR//MGLUR5//MPEP | 4678 |
287 | 1 | METABOTROPIC GLUTAMATE RECEPTOR//MGLUR5//MPEP | 3725 |
20933 | 1 | GRM1//PREFERENTIAL LOCALIZATION//H 3GLUTAMATE ACCUMULATION | 440 |
21406 | 1 | ETHYL PYRUVATE//PYRUVATE//ANTIDIARRHEIC | 420 |
35725 | 1 | GLUTAMATE PYRUVATE TRANSAMINASE GPT//BLOOD GLUTAMATE SCAVENGING//GLUTAMATE OXALOACETATE TRANSAMINASE GOT | 93 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METABOTROPIC GLUTAMATE RECEPTOR | authKW | 3459719 | 20% | 55% | 957 |
2 | MGLUR5 | authKW | 665111 | 4% | 55% | 187 |
3 | MPEP | authKW | 561351 | 3% | 71% | 122 |
4 | MGLUR | authKW | 419667 | 3% | 41% | 158 |
5 | METABOTROPIC | authKW | 312122 | 2% | 48% | 100 |
6 | MGLUR1 | authKW | 294644 | 2% | 62% | 73 |
7 | L AP4 | authKW | 290269 | 1% | 81% | 55 |
8 | MGLU5 | authKW | 288291 | 1% | 82% | 54 |
9 | LY379268 | authKW | 246556 | 1% | 82% | 46 |
10 | MGLU RECEPTORS | authKW | 238416 | 1% | 70% | 52 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 35503 | 51% | 0% | 2365 |
2 | Pharmacology & Pharmacy | 12127 | 31% | 0% | 1446 |
3 | Chemistry, Medicinal | 3431 | 9% | 0% | 406 |
4 | Biochemistry & Molecular Biology | 630 | 14% | 0% | 661 |
5 | Physiology | 585 | 5% | 0% | 227 |
6 | Psychiatry | 503 | 5% | 0% | 227 |
7 | Behavioral Sciences | 358 | 2% | 0% | 114 |
8 | Chemistry, Organic | 291 | 5% | 0% | 247 |
9 | Clinical Neurology | 113 | 4% | 0% | 178 |
10 | Critical Care Medicine | 54 | 1% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VANDERBILT NEUROSCI DRUG DISCOVERY | 186497 | 2% | 38% | 76 |
2 | VANDERBILT PROGRAM DRUG DISCOVERY | 123947 | 1% | 50% | 38 |
3 | PROGRAM TRANSLAT NEUROPHARMACOL | 52204 | 0% | 100% | 8 |
4 | HUMAN PHYSIOL PHARMACOL | 48920 | 1% | 14% | 53 |
5 | NERVOUS SYST | 46157 | 1% | 16% | 43 |
6 | NEUROSCI MED CHEM | 40820 | 1% | 26% | 24 |
7 | CHEM PHARMACOKINET SCI | 40777 | 0% | 63% | 10 |
8 | DISCOVERY SCI ADME TOX | 35525 | 0% | 78% | 7 |
9 | EXPT PET | 26102 | 0% | 100% | 4 |
10 | FAUST PHARMACEUT | 19577 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROPHARMACOLOGY | 99998 | 8% | 4% | 379 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 7506 | 4% | 1% | 173 |
3 | POLISH JOURNAL OF PHARMACOLOGY | 7167 | 1% | 4% | 27 |
4 | JOURNAL OF NEUROCHEMISTRY | 6555 | 3% | 1% | 147 |
5 | EUROPEAN JOURNAL OF PHARMACOLOGY | 6548 | 4% | 1% | 171 |
6 | NEUROSCIENCE LETTERS | 4256 | 3% | 0% | 146 |
7 | EUROPEAN JOURNAL OF NEUROSCIENCE | 4039 | 2% | 1% | 84 |
8 | MOLECULAR PHARMACOLOGY | 3941 | 2% | 1% | 78 |
9 | JOURNAL OF NEUROSCIENCE | 3840 | 3% | 0% | 145 |
10 | BRITISH JOURNAL OF PHARMACOLOGY | 3307 | 2% | 1% | 97 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METABOTROPIC GLUTAMATE RECEPTOR | 3459719 | 20% | 55% | 957 | Search METABOTROPIC+GLUTAMATE+RECEPTOR | Search METABOTROPIC+GLUTAMATE+RECEPTOR |
2 | MGLUR5 | 665111 | 4% | 55% | 187 | Search MGLUR5 | Search MGLUR5 |
3 | MPEP | 561351 | 3% | 71% | 122 | Search MPEP | Search MPEP |
4 | MGLUR | 419667 | 3% | 41% | 158 | Search MGLUR | Search MGLUR |
5 | METABOTROPIC | 312122 | 2% | 48% | 100 | Search METABOTROPIC | Search METABOTROPIC |
6 | MGLUR1 | 294644 | 2% | 62% | 73 | Search MGLUR1 | Search MGLUR1 |
7 | L AP4 | 290269 | 1% | 81% | 55 | Search L+AP4 | Search L+AP4 |
8 | MGLU5 | 288291 | 1% | 82% | 54 | Search MGLU5 | Search MGLU5 |
9 | LY379268 | 246556 | 1% | 82% | 46 | Search LY379268 | Search LY379268 |
10 | MGLU RECEPTORS | 238416 | 1% | 70% | 52 | Search MGLU+RECEPTORS | Search MGLU+RECEPTORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GOLUBEVA, AV , MOLONEY, RD , O'CONNOR, RM , DINAN, TG , CRYAN, JF , (2016) METABOTROPIC GLUTAMATE RECEPTORS IN CENTRAL NERVOUS SYSTEM DISEASES.CURRENT DRUG TARGETS. VOL. 17. ISSUE 5. P. 538 -616 | 385 | 64% | 2 |
2 | POMIERNY-CHAMIOLO, L , RUP, K , POMIERNY, B , NIEDZIELSKA, E , KALIVAS, PW , FILIP, M , (2014) METABOTROPIC GLUTAMATERGIC RECEPTORS AND THEIR LIGANDS IN DRUG ADDICTION.PHARMACOLOGY & THERAPEUTICS. VOL. 142. ISSUE 3. P. 281 -305 | 298 | 77% | 24 |
3 | FERRAGUTI, F , CREPALDI, L , NICOLETTI, F , (2008) METABOTROPIC GLUTAMATE 1 RECEPTOR: CURRENT CONCEPTS AND PERSPECTIVES.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 4. P. 536-581 | 360 | 63% | 90 |
4 | CONN, PJ , PIN, JP , (1997) PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 37. ISSUE . P. 205-237 | 149 | 81% | 2130 |
5 | SCHOEPP, DD , JANE, DE , MONN, JA , (1999) PHARMACOLOGICAL AGENTS ACTING AT SUBTYPES OF METABOTROPIC GLUTAMATE RECEPTORS.NEUROPHARMACOLOGY. VOL. 38. ISSUE 10. P. 1431 -1476 | 197 | 84% | 779 |
6 | MERCIER, MS , LODGE, D , (2014) GROUP III METABOTROPIC GLUTAMATE RECEPTORS: PHARMACOLOGY, PHYSIOLOGY AND THERAPEUTIC POTENTIAL.NEUROCHEMICAL RESEARCH. VOL. 39. ISSUE 10. P. 1876 -1894 | 226 | 83% | 8 |
7 | NISWENDER, CM , CONN, PJ , (2010) METABOTROPIC GLUTAMATE RECEPTORS: PHYSIOLOGY, PHARMACOLOGY, AND DISEASE.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 50. ISSUE . P. 295 -322 | 139 | 78% | 482 |
8 | GREGORY, KJ , NOETZEL, MJ , NISWENDER, CM , (2013) PHARMACOLOGY OF METABOTROPIC GLUTAMATE RECEPTOR ALLOSTERIC MODULATORS: STRUCTURAL BASIS AND THERAPEUTIC POTENTIAL FOR CNS DISORDERS.OLIGOMERIZATION AND ALLOSTERIC MODULATION IN G-PROTEIN COUPLED RECEPTORS. VOL. 115. ISSUE . P. 61-121 | 244 | 76% | 12 |
9 | RECASENS, M , GUIRAMAND, J , AIMAR, R , ABDULKARIM, A , BARBANEL, G , (2007) METABOTROPIC GLUTAMATE RECEPTORS AS DRUG TARGETS.CURRENT DRUG TARGETS. VOL. 8. ISSUE 5. P. 651-681 | 325 | 62% | 39 |
10 | NICOLETTI, E , BOCKAERT, J , COLLINGRIDGE, GL , CONN, PJ , FERRAGUTI, F , SCHOEPP, DD , WROBLEWSKI, JT , PIN, JP , (2011) METABOTROPIC GLUTAMATE RECEPTORS: FROM THE WORKBENCH TO THE BEDSIDE.NEUROPHARMACOLOGY. VOL. 60. ISSUE 7-8. P. 1017 -1041 | 267 | 64% | 22 |
Classes with closest relation at Level 2 |